openPR Logo
Press release

Tyrosine Kinase JAK Inhibitors market was valued at US$ 30480 million in 2022 and is anticipated to reach US$ 550830 million by 2029, witnessing a CAGR of 50.6% - Valuates Reports

09-21-2023 12:33 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Tyrosine Kinase JAK Inhibitors market was valued at US$ 30480

Tyrosine Kinase JAK Inhibitors market was valued at US$ 30480 million in 2022 and is anticipated to reach US$ 550830 million by 2029, witnessing a CAGR of 50.6% during the forecast period 2023-2029.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-36C576/Global_Tyrosine_Kinase_JAK_Inhibitors_Market_Research_Report_2020

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
These inhibitors have therapeutic application in the treatment of cancer and inflammatory diseases such as rheumatoid arthritis. There is interest in their use for various skin conditions. JAK3 inhibitors are attractive as a possible treatment of various autoimmune diseases since its functions is mainly restricted to lymphocytes. Development for a selective JAK3 inhibitors are ongoing.
In the report, we only count drugs for human beings. And the 1 unit is 1 tablet.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Tyrosine Kinase JAK Inhibitors includes Tofacitinib, Ruxolitinib and Baricitinib, and the proportion of Ruxolitinib is about 56%.
Tyrosine Kinase JAK Inhibitors is widely used in Rheumatoid Arthritis (RA), Polycythemia Vera (PCV) and Myelofibrosis (MF). The most proportion of Tyrosine Kinase JAK Inhibitors is for Rheumatoid Arthritis (RA), and the proportion is about 37%.
North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.
Market competition is intense. Pfizer, Incyte, Novartis, Eli Lilly are the leaders of the industry. Pfizer is the leader of this industry with about 42% market sharers.

Segment by Type
Tofacitinib
Ruxolitinib
Baricitinib

Segment by Application
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-36C576/global-tyrosine-kinase-jak-inhibitors

Similar report -

https://reports.valuates.com/market-reports/QYRE-Auto-4Q1256/global-janus-kinase-jak-inhibitors

https://reports.valuates.com/market-reports/QYRE-Auto-33G5892/global-jak-inhibitor-drug

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tyrosine Kinase JAK Inhibitors market was valued at US$ 30480 million in 2022 and is anticipated to reach US$ 550830 million by 2029, witnessing a CAGR of 50.6% - Valuates Reports here

News-ID: 3216927 • Views:

More Releases from Valuates Reports

AI PC Processor Market Share Driven by Rising Demand for Integrated NPU and Edge …
AI PC Processor Market The global market for AI PC Processor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-15D16860/Global_AI_PC_Processor_Market_Research_Report_2024 The AI PC Processor Market is witnessing rapid market growth, fueled by the increasing integration of artificial intelligence in personal computing devices. With advancements in edge computing and
GaN on SiC Epitaxy (Epi) Wafers Market Share Driven by High-Frequency Power Elec …
GaN on SiC Epitaxy (Epi) Wafers Market Size The global market for GaN on SiC Epitaxy (Epi) Wafers was valued at US$ 206 million in the year 2024 and is projected to reach a revised size of US$ 630 million by 2031, growing at a CAGR of 17.6% during the forecast period View sample report https://reports.valuates.com/request/sample/QYRE-Auto-0N15277/Global_GaN_on_SiC_Epitaxy_Epi_Wafers_Market_Research_Report_2023 The GaN on SiC Epitaxy (Epi) Wafers Market is witnessing remarkable growth, propelled by increasing demand for high-power,
Thin Film Lithium Niobate (TFLN) Wafer Market Share Driven by Advancements in In …
TFLN Wafer Market Size The global market for TFLN Wafer was valued at US$ 108 million in the year 2024 and is projected to reach a revised size of US$ 1655 million by 2031, growing at a CAGR of 46.0% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-16D19632/Global_TFLN_Wafer_Market_Research_Report_2025 The Thin Film Lithium Niobate (TFLN) Wafer Market is experiencing substantial growth, fueled by rapid advancements in optical communications, 5G technology, and photonic integrated circuits. TFLN
Graphite Wafer Carrier Market Share Driven by Expanding Semiconductor Fabricatio …
Graphite Wafer Carrier Market The global market for Graphite Wafer Carrier was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-5N13209/Global_Graphite_Wafer_Carrier_Market_Research_Report_2023 The Graphite Wafer Carrier Market is gaining traction as semiconductor manufacturing processes become increasingly advanced and contamination-sensitive. Graphite wafer carriers are essential for wafer handling and protection during

All 5 Releases


More Releases for JAK

Key Trends Influencing the Growth of the Janus Kinase (JAK) Inhibitors Market in …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Janus Kinase (JAK) Inhibitors Market Through 2025? The market size of Janus Kinase (JAK) inhibitors has experienced a quick growth over the recent years. The market, which stood at $20.19 billion in 2024, is projected to see a rise to $23.56 billion
Vitiligo Treatment Innovation Accelerates with JAK Inhibitors and Novel Immunoth …
Leading companies, such as Incyte Corporation, TWi Biotechnology, Amgen, Pfizer, Arcutis Biotherapeutics, AnaptysBio, and others, are actively advancing promising drug candidates aimed at improving the Vitiligo treatment landscape. Let's explore how this will impact the Vitiligo treatment landscape. DelveInsight's "Vitiligo Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/vitiligo-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers comprehensive insights on the vitiligo pipeline, showcasing a dynamic landscape of emerging therapies and a promising outlook for patients suffering from this challenging autoimmune skin
Global Jak And Pi3k Signaling Pathway Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Jak And Pi3k Signaling Pathway market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The JAK and PI3K signaling pathway market is experiencing significant growth due to the increasing
Leading Growth Driver in the Janus Kinase (JAK) Inhibitors Market in 2025: Surgi …
Which drivers are expected to have the greatest impact on the over the janus kinase (jak) inhibitors market's growth? The escalating occurrences of autoimmune disorders are anticipated to stimulate the expansion of the Janus kinase (JAK) inhibitors market. These disorders involve a broad spectrum of abnormalities within the immune system where it erroneously attacks and destroys healthy cells, tissues, and organs. The therapeutic benefits of Janus Kinase (JAK) inhibitors for autoimmune
Janus Kinase (JAK) Inhibitor Pipeline Therapeutics Assessment Report 2024 (Updat …
DelveInsight's, "Janus Kinase Inhibitor Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Janus Kinase (JAK) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Janus Kinase
Janus kinase (JAK) Inhibitors Competitive Landscape Report 2024
DelveInsight's, "Janus kinase inhibitors Competitive landscape 2024" report provides comprehensive insights about 40+ Janus kinase Inhibitors Companies and 45+ drugs in Janus kinase inhibitors Competitive landscape. It covers the Janus kinase Inhibitors therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Janus kinase Inhibitors Report • DelveInsight's Janus kinase Inhibitors report depicts a robust space